These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Quantitative in vivo measurement of central benzodiazepine receptors in the brain of cats by use of positron-emission tomography and [11C]flumazenil. Shimada Y; Kiyosawa M; Nariai T; Oda K; Toyama H; Ono K; Senda M; Ishiwata K Am J Vet Res; 2003 Aug; 64(8):999-1002. PubMed ID: 12926592 [TBL] [Abstract][Full Text] [Related]
5. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Ryvlin P; Bouvard S; Le Bars D; De Lamérie G; Grégoire MC; Kahane P; Froment JC; Mauguière F Brain; 1998 Nov; 121 ( Pt 11)():2067-81. PubMed ID: 9827767 [TBL] [Abstract][Full Text] [Related]
6. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy. Juhász C; Chugani DC; Muzik O; Watson C; Shah J; Shah A; Chugani HT Neurology; 2000 Sep; 55(6):825-35. PubMed ID: 10994004 [TBL] [Abstract][Full Text] [Related]
8. Anatomical accuracy of abdominal lesion localization. Retrospective automatic rigid image registration between FDG-PET and MRI. Kiefer A; Kuwert T; Hahn D; Hornegger J; Uder M; Ritt P Nuklearmedizin; 2011; 50(4):147-54. PubMed ID: 21594303 [TBL] [Abstract][Full Text] [Related]
9. Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy. Padma MV; Simkins R; White P; Satter M; Christian BT; Dunigan K; Lee C; Jacobs M; Mukherjee J; Mantil JC Neurol India; 2004 Dec; 52(4):457-62. PubMed ID: 15626833 [TBL] [Abstract][Full Text] [Related]
10. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy. Juhász C; Nagy F; Watson C; da Silva EA; Muzik O; Chugani DC; Shah J; Chugani HT Neurology; 1999 Dec; 53(9):2037-45. PubMed ID: 10599778 [TBL] [Abstract][Full Text] [Related]
11. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Muzik O; da Silva EA; Juhasz C; Chugani DC; Shah J; Nagy F; Canady A; von Stockhausen HM; Herholz K; Gates J; Frost M; Ritter F; Watson C; Chugani HT Neurology; 2000 Jan; 54(1):171-9. PubMed ID: 10636144 [TBL] [Abstract][Full Text] [Related]
12. A standardized method for the construction of tracer specific PET and SPECT rat brain templates: validation and implementation of a toolbox. Vállez Garcia D; Casteels C; Schwarz AJ; Dierckx RA; Koole M; Doorduin J PLoS One; 2015; 10(3):e0122363. PubMed ID: 25823005 [TBL] [Abstract][Full Text] [Related]
13. Parametric images of benzodiazepine receptor concentration using a partial-saturation injection. Delforge J; Spelle L; Bendriem B; Samson Y; Syrota A J Cereb Blood Flow Metab; 1997 Mar; 17(3):343-55. PubMed ID: 9119907 [TBL] [Abstract][Full Text] [Related]
14. Quantitative comparisons of image registration techniques based on high-resolution MRI of the brain. Strother SC; Anderson JR; Xu XL; Liow JS; Bonar DC; Rottenberg DA J Comput Assist Tomogr; 1994; 18(6):954-62. PubMed ID: 7962808 [TBL] [Abstract][Full Text] [Related]
15. Early detection of irreversibly damaged ischemic tissue by flumazenil positron emission tomography in cats. Heiss WD; Graf R; Fujita T; Ohta K; Bauer B; Löttgen J; Wienhard K Stroke; 1997 Oct; 28(10):2045-51; discussion 2051-2. PubMed ID: 9341717 [TBL] [Abstract][Full Text] [Related]
16. [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors. Gründer G; Siessmeier T; Lange-Asschenfeldt C; Vernaleken I; Buchholz HG; Stoeter P; Drzezga A; Lüddens H; Rösch F; Bartenstein P Eur J Nucl Med; 2001 Oct; 28(10):1463-70. PubMed ID: 11685488 [TBL] [Abstract][Full Text] [Related]
17. Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain. Casteels C; Vermaelen P; Nuyts J; Van Der Linden A; Baekelandt V; Mortelmans L; Bormans G; Van Laere K J Nucl Med; 2006 Nov; 47(11):1858-66. PubMed ID: 17079820 [TBL] [Abstract][Full Text] [Related]
18. Multi-Atlas-Based Attenuation Correction for Brain 18F-FDG PET Imaging Using a Time-of-Flight PET/MR Scanner: Comparison with Clinical Single-Atlas- and CT-Based Attenuation Correction. Sekine T; Burgos N; Warnock G; Huellner M; Buck A; Ter Voert EE; Cardoso MJ; Hutton BF; Ourselin S; Veit-Haibach P; Delso G J Nucl Med; 2016 Aug; 57(8):1258-64. PubMed ID: 27013697 [TBL] [Abstract][Full Text] [Related]
19. PET-MR image fusion in soft tissue sarcoma: accuracy, reliability and practicality of interactive point-based and automated mutual information techniques. Somer EJ; Marsden PK; Benatar NA; Goodey J; O'Doherty MJ; Smith MA Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):54-62. PubMed ID: 12483410 [TBL] [Abstract][Full Text] [Related]
20. PET attenuation correction using synthetic CT from ultrashort echo-time MR imaging. Roy S; Wang WT; Carass A; Prince JL; Butman JA; Pham DL J Nucl Med; 2014 Dec; 55(12):2071-7. PubMed ID: 25413135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]